Lotus Pharmaceutical Co., Ltd.

TWSE:1795 Stock Report

Market Cap: NT$84.0b

Lotus Pharmaceutical Dividend

Dividend criteria checks 1/6

Lotus Pharmaceutical ist ein dividendenzahlendes Unternehmen mit einer aktuellen Rendite von 1.26%, die durch die Erträge gut gedeckt ist.

Key information

1.1%

Dividend yield

23%

Payout ratio

Industry average yield1.7%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per shareNT$15.52
Dividend yield forecast in 3Y2.3%

Recent dividend updates

Recent updates

Lotus Pharmaceutical's (TWSE:1795) Solid Profits Have Weak Fundamentals

Mar 22
Lotus Pharmaceutical's (TWSE:1795) Solid Profits Have Weak Fundamentals

These 4 Measures Indicate That Lotus Pharmaceutical (TPE:1795) Is Using Debt Extensively

Apr 04
These 4 Measures Indicate That Lotus Pharmaceutical (TPE:1795) Is Using Debt Extensively

Lotus Pharmaceutical Co., Ltd.'s (TPE:1795) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Mar 09
Lotus Pharmaceutical Co., Ltd.'s (TPE:1795) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Did You Miss Lotus Pharmaceutical's (TPE:1795) 64% Share Price Gain?

Feb 11
Did You Miss Lotus Pharmaceutical's (TPE:1795) 64% Share Price Gain?

Should You Use Lotus Pharmaceutical's (TPE:1795) Statutory Earnings To Analyse It?

Jan 21
Should You Use Lotus Pharmaceutical's (TPE:1795) Statutory Earnings To Analyse It?

Is Lotus Pharmaceutical (TPE:1795) Using Too Much Debt?

Dec 31
Is Lotus Pharmaceutical (TPE:1795) Using Too Much Debt?

I Ran A Stock Scan For Earnings Growth And Lotus Pharmaceutical (TPE:1795) Passed With Ease

Dec 10
I Ran A Stock Scan For Earnings Growth And Lotus Pharmaceutical (TPE:1795) Passed With Ease

Lotus Pharmaceutical Co., Ltd. Just Missed EPS By 6.5%: Here's What Analysts Think Will Happen Next

Nov 19
Lotus Pharmaceutical Co., Ltd. Just Missed EPS By 6.5%: Here's What Analysts Think Will Happen Next

Stability and Growth of Payments

Fetching dividends data

Stabile Dividende: Während die Dividendenzahlungen stabil waren, zahlt 1795 seit weniger als 10 Jahren eine Dividende.

Wachsende Dividende: 1795Die Dividendenzahlungen des Unternehmens sind gestiegen, aber das Unternehmen zahlt erst seit 2 Jahren eine Dividende.


Dividend Yield vs Market

Lotus Pharmaceutical Dividend Yield vs Market
How does 1795 dividend yield compare to the market?
SegmentDividend Yield
Company (1795)1.1%
Market Bottom 25% (TW)1.8%
Market Top 25% (TW)4.6%
Industry Average (Pharmaceuticals)1.7%
Analyst forecast in 3 Years (1795)2.3%

Bemerkenswerte Dividende: 1795Die Dividende des Unternehmens (1.26%) ist im Vergleich zu den unteren 25 % der Dividendenzahler auf dem Markt TW (1.98%) nicht bemerkenswert.

Hohe Dividende: 1795Die Dividende des Unternehmens (1.26%) ist im Vergleich zu den besten 25% der Dividendenzahler auf dem Markt TW (5.16%) niedrig.


Earnings Payout to Shareholders

Abdeckung der Erträge: Mit seiner niedrigen Ausschüttungsquote (23.3%) sind die Dividendenzahlungen von 1795 gut durch die Erträge gedeckt.


Cash Payout to Shareholders

Cashflow-Deckung: 1795 zahlt eine Dividende, aber das Unternehmen hat keinen freien Cashflow.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.